Literature DB >> 31261095

Neonatal Hemophagocytic Lymphohistiocytosis.

Josef McLean1, Roia Katebian1, Eugene Suh1, Kamran Mirza2, Sachin Amin1.   

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is extremely rare in the neonatal period. The incidence of neonatal HLH is not confirmed and may range from 1 in 50,000 to 150,000. The incidence varies based on ethnicity, particularly in populations in which consanguinity is common. HLH is associated with a high fatality rate and poor prognosis, making it important to recognize and diagnose it early. This review will concentrate primarily on the diagnosis and management of neonatal HLH.
Copyright © 2019 by the American Academy of Pediatrics.

Entities:  

Mesh：

Year:  2019        PMID： 31261095     DOI： 10.1542/neo.20-6-e316

Source DB:  PubMed          Journal:  Neoreviews        ISSN： 1526-9906


  5 in total

Review 1.  Inborn Errors of Immunity With Fetal or Perinatal Clinical Manifestations.

Authors:  Magda Carneiro-Sampaio; Adriana Almeida de Jesus; Silvia Yumi Bando; Carlos Alberto Moreira-Filho
Journal:  Front Pediatr       Date:  2022-05-06       Impact factor: 3.569

2.  Haemophagocytic lymphohistiocytosis: Five years' experience at tertiary hospitals in Free State Province, South Africa.

Authors:  M Nienkemper; J Malherbe; C Barrett
Journal:  South Afr J Crit Care       Date:  2020-12-01

Review 3.  Inborn Errors of Immunity in the Premature Infant: Challenges in Recognition and Diagnosis.

Authors:  Scott M Gordon; Amy E O'Connell
Journal:  Front Immunol       Date:  2021-12-24       Impact factor: 8.786

4.  Epidemiology and Outcomes of Neonatal Hemophagocytic Lymphohistiocytosis.

Authors:  Niveditha Balakumar; Prithvi Sendi; Balagangadhar R Totapally
Journal:  Front Pediatr       Date:  2022-04-26       Impact factor: 3.418

5.  The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.

Authors:  J M Krei; H J Møller; J B Larsen
Journal:  Clin Exp Immunol       Date:  2020-11-23       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.